BackCeryvyn Therapeutics Limited Overview

Ceryvyn Therapeutics Limited Receivables

Ceryvyn Therapeutics Limited's receivables is $420K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$421066.00
↓ 94.73% YoYΔ $-7.56M vs prior year quarter

Peer trimmed avg / median

Loading

Ceryvyn Therapeutics Limited Receivables History

Loading

Ceryvyn Therapeutics Limited vs. peers: Receivables Comparison

Loading

Ceryvyn Therapeutics Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ceryvyn Therapeutics Limited (CKDXF) FAQ

As of the most recent data (December 2025), CKDXF shows a receivables of $420K. That compares with $8M in the prior-year period — down 94.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CKDXF's receivables is now $420K (was $8M) — a 94.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ceryvyn Therapeutics Limited is outperforming or lagging.

Tracking CKDXF's receivables over time shows whether Ceryvyn Therapeutics Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $420K That compares with $8M in the prior-year period — down 94.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Ceryvyn Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $420K) with ownership activity and broader fundamentals.

Ceryvyn Therapeutics Limited's receivables is $420K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.